Breakthrough daptomycin-, linezolid-, vancomycin-resistant Enterococcus faecium bacteremia during protracted daptomycin therapy: A case report.
IDCases
; 29: e01593, 2022.
Article
en En
| MEDLINE
| ID: mdl-35966277
CLABSI, central line-associated bloodstream infection; CPT, ceftaroline; Case report; DAP, daptomycin; DLVRE, daptomycin-, linezolid-, vancomycin-resistant Enterococcus faecium; DNSE, daptomycin-non-susceptible enterococci; Daptomycin-resistance; Efm, Enterococcus faecium; IA, intraabdominal; LLQ, left lower quadrant; LZD, linezolid; Linezolid-resistance; MDR, multidrug resistant; MIC, minimal inhibitory concentration; PBP5, penicillin binding protein 5; PICC, peripherally inserted central catheter; POD, post-operative day; ST, sequence type; Synergy antimicrobial resistance testing; Vancomycin-resistant Enterococcus faecium; WGS, whole genome sequencing; Whole genome sequencing; p15, plasmids 15
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Guideline
Idioma:
En
Revista:
IDCases
Año:
2022
Tipo del documento:
Article